anidulafungin has been researched along with Fungal Lung Diseases in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chan, TS; Chim, CS; Gill, H; Hwang, YY; Khong, PL; Kwong, YL; Leung, AY; Lie, AK; Loong, F; Sim, J; Tse, AC; Tse, E | 1 |
| Schnadig, VJ; Shah, SK; Terasaki, JM; Valentine, VG | 1 |
| Gadea, I; Mensa, J | 1 |
| Accarpio, F; Di Giorgio, A; Falcone, M; Sammartino, P; Sibio, S; Vena, A; Venditti, M | 1 |
| Guarro, J; Pastor, FJ | 1 |
| Bacher, J; Bell, A; Callender, DP; Groll, AH; McMillian, CL; Petraitiene, R; Petraitis, V; Schaufele, RL; Sein, T; Walsh, TJ | 1 |
| Bacher, JS; Groll, AH; Lyman, CA; Mickiene, D; Petraitiene, R; Petraitis, V; Piscitelli, SC; Walsh, TJ | 1 |
2 review(s) available for anidulafungin and Fungal Lung Diseases
| Article | Year |
|---|---|
[Potential of anidulafungin in combined therapy].
Topics: Amphotericin B; Anidulafungin; Animals; Antifungal Agents; Azoles; Clinical Trials as Topic; Drug Evaluation, Preclinical; Drug Synergism; Drug Therapy, Combination; Echinocandins; Encephalomyelitis; Fungemia; Guinea Pigs; Humans; Lung Diseases, Fungal; Mice; Mycoses | 2008 |
[Anidulafungin: experimental therapy of fungal infections in animal models].
Topics: Anidulafungin; Animals; Antifungal Agents; Aspergillosis; Candidiasis; Disease Models, Animal; Echinocandins; Lung Diseases, Fungal | 2008 |
5 other study(ies) available for anidulafungin and Fungal Lung Diseases
| Article | Year |
|---|---|
Breakthrough invasive fungal diseases during echinocandin treatment in high-risk hospitalized hematologic patients.
Topics: Adenine Nucleotides; Adult; Anidulafungin; Antibiotic Prophylaxis; Antifungal Agents; Antimetabolites, Antineoplastic; Arabinonucleosides; Candida; Candidiasis, Invasive; Caspofungin; China; Clofarabine; Cohort Studies; Cross Infection; Echinocandins; Fusariosis; Fusarium; Hematologic Diseases; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Lipopeptides; Lung Diseases, Fungal; Micafungin; Retrospective Studies; Risk Factors | 2014 |
Airway complication contributing to disseminated fusariosis after lung transplantation.
Topics: Aged; Anidulafungin; Antifungal Agents; Drug Therapy, Combination; Echinocandins; Female; Fusariosis; Fusarium; Humans; Lung Diseases, Fungal; Lung Transplantation; Voriconazole | 2014 |
Septic bilateral pulmonary candidiasis successfully treated with anidulafungin therapy in two patients with peritoneal carcinomatosis.
Topics: Aged; Anidulafungin; Antifungal Agents; Candidiasis; Carcinoma; Echinocandins; Female; Humans; Lung Diseases, Fungal; Middle Aged; Peritoneal Neoplasms; Radiography, Thoracic; Tomography, X-Ray Computed; Treatment Outcome | 2010 |
Antifungal efficacy, safety, and single-dose pharmacokinetics of LY303366, a novel echinocandin B, in experimental pulmonary aspergillosis in persistently neutropenic rabbits.
Topics: Amphotericin B; Anidulafungin; Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Dose-Response Relationship, Drug; Echinocandins; Female; Lung Diseases, Fungal; Neutropenia; Peptides, Cyclic; Rabbits | 1998 |
Pharmacokinetic and pharmacodynamic modeling of anidulafungin (LY303366): reappraisal of its efficacy in neutropenic animal models of opportunistic mycoses using optimal plasma sampling.
Topics: Anidulafungin; Animals; Antifungal Agents; Aspergillosis; Candidiasis; Disease Models, Animal; Echinocandins; Female; Lung Diseases, Fungal; Neutropenia; Opportunistic Infections; Peptides, Cyclic; Rabbits; Tissue Distribution | 2001 |